Corcept Therapeutics, Inc. (CORT)
51.38
-0.77
(-1.48%)
USD |
NASDAQ |
May 07, 10:58
Corcept Therapeutics SG&A Expense (TTM) : 503.42M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 10.88B |
| Integer Holdings Corp. | 219.30M |
| Stryker Corp. | 8.632B |
| Supernus Pharmaceuticals, Inc. | 395.62M |
| Terns Pharmaceuticals, Inc. | 32.24M |